Form 8-K · Current report
Ameren 8-K, filed Sep 18, 2026
- Filed
- CIK
- 0001002910
- Accession no.
- 0001104659-26-108859
Summary
Ameren Corporation sold $900 million principal amount of Junior Subordinated Notes due 2057 on September 18, 2026, receiving net proceeds of $891.0 million before expenses, with Barclays Capital Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., and Truist Securities, Inc. acting as underwriter representatives.
Key points
- The notes were offered under an effective Form S-3 registration statement dated August 4, 2026, with a prospectus supplement dated September 8, 2026.
- The Bank of New York Mellon Trust Company, N.A. serves as trustee under an indenture dated September 1, 2026.
- Ameren filed the Form 8-K to report exhibits related to the offering, including the underwriting agreement, indenture, global notes, and legal opinions.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
ITEM 8.01 Other Events. On September 18, 2026, Ameren Corporation (“Ameren”) sold $900 million principal amount of its Junior Subordinated Notes due 2057 (the “Notes”). The Notes were offered pursuant to a Registration Statement on Form S-3 (File No. 333-297949), which became effective on August 4, 2026, and a Prospectus Supplement dated September 8, 2026, to a Prospectus dated August 4, 2026. Ameren received net offering proceeds of $891.0 million, before expenses, upon closing of the transaction. This Current Report on Form 8-K is being filed to report as exhibits certain documents in connection with the offering of the Notes. ITEM 9.01 Financial Statements and Exhibits. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.